Davendra Sohal, MD, MPH

216.444.8258

Davendra Sohal, MD, MPH
Department: Hematology and Oncology
Associate Staff
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.8258
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Davendra Sohal, MD, MPH, is an oncologist at Cleveland Clinic Taussig Cancer Institute. Clinically, his primary interest is caring for patients with gastrointestinal malignancies, including clinical trials of new treatments for these patients.

Dr. Sohal earned his medical degree from the All India Institute of Medical Sciences in New Delhi, India.He completed residency training and a year as a Chief Resident in Internal Medicine at the Jacobi Medical Center of the Albert Einstein College of Medicine in Bronx, NY. Dr. Sohal completed a fellowship in Hematology/Oncology at the University of Pennsylvania in Philadelphia, PA.

Dr. Sohal has also completed graduate training in epidemiology and biostatistics at the University of Alabama at Birmingham. He has published several articles in peer-reviewed journals and presented at various international meetings. In addition to teaching awards, Dr. Sohal received an American Society of Hematology (ASH) Trainee Research Award and an American Society of Clinical Oncology (ASCO) Young Investigator Award.

Education & Fellowships

Fellowship - University of Pennsylvania / Pennsylvania Hospital
Hematology/Oncology
Philadelphia, PA USA
2012
Residency - Jacobi Medical Center, Albert Einstein College of Medicine
Internal Medicine
Bronx, NY
2009
Graduate - University of Alabama at Birmingham
Birmingham, AL USA
2005
Medical School - All India Institute of Medical Sciences
New Delhi India
2002

Certifications

  • Internal Medicine
  • Internal Medicine- Medical Oncology

Treatment & Services

  • Clinical Trials
  • Experimental Therapeutics

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Sohal's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

Languages Spoken

  • English
  • Hindi
  • Panjabi
Cleveland Clinic Mobile Site